MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
We are looking for patient-inspired, passionate and experienced Regional Account Managers (RAM) for our Metabolics team with demonstrated success in new product launches. The RAM will have the opportunity to run their own business within a specified geography, including N. California, Oregon, Washington, Idaho, Montana, and Alaska for two marketing products CHOLBAM, and CTEXLI. We will have a preference for candidates living in Northern California and Washington State.
This top performing regional business owner will possess experience in business ownership, leadership, analytics, and the implementation of innovative solutions. The RAM will formulate an effective regional strategy focusing on Geneticist, as their core customer. They will be tasked with establishing short- and long-term business tactics. It will be the responsibility of the RAM to identify key priorities within territories and create and implement business plan that is organizationally approved and fully compliant with all laws. The RAM will be accountable for improving diagnosis rates of all on label indications within their region, growing Cholbam & CTEXLI sales in the metabolic market, and effectively partnering across the sales organization to ensure all goals are met.
The successful RAM will have courage, talent and dedication to seek solutions that can make a meaningful impact within territory or broader team. The ideal candidates are detail orientated, self-structured in their approach to their work, with the ability to manage relationships at all levels. The RAM will have proven presentation and partner management skills and thrive in a rapid paced and dynamic environment within a culture that relies on a patient centric and teamwork orientated approach.
PRIMARY RESPONSIBILITIES
- As Regional Account Manager, you are the regional business owner with focus on increasing HCP awareness and understanding of promoted Mirum products
- Identifies and establishes strong relationships with key thought leaders and customers; demonstrated ability to recognize and devote the necessary time and resources needed to engage with HCP’s to create advocates
- Possesses an entrepreneurial approach with a focus on ownership and accountability to maximize/exceed individual and company goals
- Understand healthcare trends in the Rare Disease community and apply strategies to mitigate account access challenges
- Employ strong organizational and analytical skills to optimize growth, including the ability to analyze business data to develop strategic and actionable business plans
- Demonstrates and enhances Mirum’s culture of compliance, integrity, and transparency
- Development and maintain strong partnerships across commercial, compliance, medical affairs functions.
- Drive change through influence and innovation
REQUIRED EXPERIENCE
- 5+ years of progressive business experience in healthcare or biotech industry, inclusive of 3 years of field-based experience in account management, sales and field reimbursement
- Experience working in ambiguous spaces where patient finding may take coordination across specialties
- Experience working with ICD-10 based leads
- Bachelor’s degree or higher
QUALIFICATIONS
- Experience growing mature brands
- Proven experience working within Hospitals, Academic Institutions, and the community calling on intradisciplinary teams
- Track record of researching and problem-solving complex issues impacting HCP’s while mitigating barriers to patients access to care
- Proven record of success through teamwork and execution
- Experiencing managing a large multi-state geography preferred
- Track record of operating in accordance with all regulations as well as company policy and procedures
- Brand experience working across multispecialty including Genetics
- Demonstrates high ethical and performance standards with all business contacts
- Approximately 70% travel is required including overnight travel as needed
- Some travel and attendance on evenings and weekends for regional and national meetings, conferences and advocacy support events
KNOWLEDGE, SKILLS, AND ABILITIES
- Motivational and interpersonal communication
- Demonstrates the ability to prospect new targets.
- Ability to navigate the organization to achieve goals. Strong collaborator
- Strong presentation and management skills
- Scientific acumen and proficiency in highly specialized and complex diseases
- Detail oriented and precision while able to see “big picture”.
- Assertiveness, pro-activity, professionalism, and confidence.
- Extraordinary commitment to customer experience and standards of excellence
- Excellent organizational skills.
- Self-motivated and ability to deal with ambiguity and problem solve
The salary range for this position is $195,000 to $205,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
Similar Jobs
.png)
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
